Gauss Surgical raises $12.6M Series B

What does Gauss Surgical do?

Gauss Surgical,  is a biotechnology company which develops a mobile vision based platform for real time and exact blood loss measurement during surgery. The company is the founder of Triton, the world’s 1^st and only platform that monitors surgical blood loss in real time.

The company provides a mobile vision platform for the operation theatre. It develops beautiful apps for Apple operating system backed by HIPAA-compliant technical stack and sophisticated algorithms  for enabling real time monitoring during operations.

How much Gauss Surgical was funded?

The company raised $12.6M in Series B on March 30, 2016 from Lifeforce Ventures, StanfordStartX Fund, Summation Health Ventures, Jump Capital, Promus Ventures and Providence Ventures.

Previous funding

• $805k on December 31, 2011 from Promus Ventures
• $1.42M on February 1, 2013
• $3.13M on September, 2013 from Joe Mandato, Mike Levinthal, Rick Magnuson, Taube Investment Partners,  Jay Watkins, Promus Ventures and Stanford University.
• $1.5M on October 30, 2014 from Promus Ventures
• $12M in Series A on August 26, 2015 from Promus Ventures, Lifeforce Ventures and Summation Health Ventures

What is next for Gauss Surgical?

Gauss Surgical has appointed two new member, Mike Collett and Daniel Galles, Managing partner of Promus Ventures and partner at Providence Ventures as Board of Directors and Dr. Garrett Vygantas as Board observer.

More about Gauss Surgical

The company was founded in 2011 by Siddarth Satish. It has its headquarters in Los Altos, California. The company has created and refined a revolutionary technology that will help many patients in the future. The company’s vision is helping healthcare providers and patients by using the data for the improvement and augmentation of real time decision making with complex care setting such as the operation room.  The company’s aim is to have all the health systems in the country take advantage of its Triton.